Ritalin’s active ingredient is methylphenidate hydrochloride, a central nervous system stimulant. The rest of the tablet is a mix of inactive ingredients like lactose, starch, sugar, and dyes that hold the pill together and give it its distinctive color. What’s inside varies slightly depending on whether you’re taking the immediate-release tablet or the extended-release capsule.
The Active Ingredient: Methylphenidate
Every Ritalin tablet contains one active compound: methylphenidate hydrochloride. Its molecular formula is C₁₄H₁₉NO₂·HCl, and its full chemical name is methyl α-phenyl-2-piperidineacetate hydrochloride. In plain terms, it’s a synthetic molecule built around a piperidine ring (a six-membered ring containing nitrogen) attached to a phenyl group, with a small ester chain hanging off the side.
Methylphenidate is manufactured through a multi-step chemical process. It starts with two precursors, phenylacetonitrile and chloropyridine, which are combined at high temperature in a solvent. That intermediate product goes through several transformations, including conversion to an ester, and finally the pyridine ring is hydrogenated into a piperidine ring using a platinum catalyst. The result is the methylphenidate molecule, which is then combined with hydrochloric acid to form the stable hydrochloride salt used in tablets.
Inactive Ingredients in Immediate-Release Tablets
The active drug makes up only a small fraction of each tablet’s weight. The bulk is filler, binder, and coating materials. For standard Ritalin immediate-release tablets, the FDA-approved label lists these inactive ingredients:
- Lactose: a milk-derived sugar used as a filler in all three strengths
- Starch: a binder that helps the tablet hold its shape (in 5 mg and 10 mg tablets)
- Sucrose: table sugar, used as another filler and sweetener
- Magnesium stearate: a lubricant that prevents the powder from sticking to manufacturing equipment
- Polyethylene glycol: a coating agent that helps with swallowing
- Talc: a flow agent that keeps the powder mixture moving smoothly during production
- Tragacanth: a natural gum used as a binder (in 20 mg tablets only)
Each tablet strength also gets its color from a specific dye. The 5 mg and 20 mg tablets contain D&C Yellow No. 10, while the 10 mg tablets use FD&C Green No. 3. If you have sensitivities to artificial dyes or lactose, these are worth noting.
What’s Different in Extended-Release Capsules
Ritalin LA (long-acting) capsules use a completely different set of inactive ingredients because they rely on a specialized delivery system called SODAS, or Spheroidal Oral Drug Absorption System. Each capsule is filled with tiny beads: half are designed to dissolve immediately, and half are coated with an enteric layer that delays their release. This creates two waves of medication from a single dose.
The inactive ingredients in Ritalin LA include ammonio methacrylate copolymer and methacrylic acid copolymer (the polymers that control how the beads dissolve), sugar spheres (the core that the drug is layered onto), gelatin (for the capsule shell), triethyl citrate (a plasticizer that keeps the coating flexible), talc, polyethylene glycol, and titanium dioxide. Various iron oxides provide color depending on the capsule strength. Ritalin LA comes in 10, 20, 30, and 40 mg capsules.
Standard extended-release tablets (not the LA capsules) are available in 18 mg, 27 mg, 36 mg, and 54 mg strengths. These are film-coated and color-coded: yellow for 18 mg, gray for 27 mg, white for 36 mg, and red-brown for 54 mg.
How Methylphenidate Works in the Brain
Methylphenidate increases the levels of two chemical messengers in the brain: dopamine and norepinephrine. It does this by blocking the transporter proteins that normally vacuum these chemicals back up after they’ve been released. With the transporters blocked, dopamine and norepinephrine linger longer in the gaps between nerve cells, strengthening the signals involved in attention, focus, and impulse control.
For years, the therapeutic benefit was attributed mainly to its effect on dopamine transporters. But methylphenidate actually has a higher affinity for norepinephrine transporters. At typical clinical doses (0.35 to 0.55 mg per kilogram of body weight), the drug occupies 70% to 80% of norepinephrine transporters. This suggests that norepinephrine plays a larger role in the drug’s effects on attention than was previously appreciated.
Regulatory Classification
Methylphenidate is classified as a Schedule II controlled substance by the DEA, the same category as amphetamine and methamphetamine. Schedule II drugs are recognized as having legitimate medical uses but carry a high potential for abuse that could lead to severe psychological or physical dependence. This classification means Ritalin prescriptions cannot be called in by phone in most states, refills are not allowed on a single prescription, and manufacturing quotas are set by the federal government each year.